生物保存市場の規模、シェア、成長分析：製品別、生物標本別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

生物保存の世界市場規模は2023年に28億米ドルと評価され、2024年の35億9,000万米ドルから2032年には263億8,000万米ドルに成長し、予測期間（2025～2032年）のCAGRは28.3％で成長する見通しです。

生物保存市場は、技術の進歩とDNA、組織、幹細胞を含むバイオマスや生物学的産物の保存に対する需要の増加によって、顕著な成長を遂げています。マイクロアレイや予測モデリング統合などの最近の技術革新は、生物保存のプロセスを合理化し、時間、コスト、複雑さを軽減しています。さらに、マルチプレックス細胞イメージング・プラットフォームは生物保存の機能を強化し、心臓病学や婦人科学などの専門分野での採用を促進しています。慢性疾患の増加に伴い、免疫療法やワクチンなどの生物学的ソリューションの開発への関心が高まっており、生物保存の需要をさらに促進しています。また、官民の協力関係も研究開発イニシアティブへの資金提供を後押ししており、ヘルスケア支出の増加が今後数年間の継続的な市場拡大を促進すると予想されています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制分析
• 技術分析

生物保存市場規模：製品別

• 市場概要
• 生物保存媒体
  • 凍結保存媒体
  • 低温保存媒体
• 生物保存装備
  • 温度制御システム
  • 冷凍庫
  • 極低温貯蔵システム
  • 解凍装置
  • 冷蔵庫
  • 警報監視システム
  • インキュベーター
  • 遠心分離機
  • その他生物保存機器
• 生物保存アクセサリー

生物保存市場規模：生物標本別

• 市場概要
• ヒト組織サンプル
• 臓器
• 幹細胞
• その他の生体標本

生物保存市場規模：用途別

• 市場概要
• 研究用途
• 治療用途
• その他の用途

生物保存市場規模：エンドユーザー別

• 市場概要
• バイオバンク
• 遺伝子バンク
• 病院
• その他のエンドユーザー

生物保存市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

主要企業プロファイル

• Thermo Fisher Scientific Inc.（United States）
• Merck KGaA（Germany）
• BioLife Solutions, Inc.（United States）
• STEMCELL Technologies（Canada）
• Helmer Scientific Inc.（United States）
• PrincetonCryo（United States）
• OPS Diagnostics（United States）
• ThermoGenesis Holdings, Inc.（United States）
• Avantor, Inc.（United States）
• Bio-Techne Corporation（United States）
• Exact Sciences Corporation（United States）
• Worthington Industries, Inc.（United States）
• Chart Industries, Inc.（United States）
• Azenta US, Inc.（United States）
• LabVantage Solutions, Inc.（United States）
• Qiagen N.V.（Netherlands）
• Taylor-Wharton Cryogenics LLC（United States）
• PHC Holdings Corporation（Japan）
• Panasonic Corporation（Japan）
• Lifeline Scientific, Inc.（United States）

結論と提言

Global Biopreservation Market size was valued at USD 2.8 billion in 2023 and is poised to grow from USD 3.59 billion in 2024 to USD 26.38 billion by 2032, growing at a CAGR of 28.3% during the forecast period (2025-2032).

The biopreservation market is experiencing notable growth, driven by advancements in technology and an increasing demand for the preservation of biomass and biological products, including DNA, tissues, and stem cells. Recent innovations, such as microarrays and predictive modeling integration, have streamlined the biopreservation process, reducing time, costs, and complexity. Additionally, multiplex cellular imaging platforms enhance biopreservation capabilities, fostering adoption in specialties like cardiology and gynecology. With a rise in chronic diseases, there's heightened interest in developing biological solutions such as immunotherapies and vaccines, further propelling biopreservation demand. Collaborations between public and private sectors are also boosting funding for R&D initiatives, while growing healthcare expenditures are expected to drive continued market expansion in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biopreservation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biopreservation Market Segments Analysis

Global Biopreservation Market is segmented by Product, Biospecimen, Application, End User and region. Based on Product, the market is segmented into Biopreservation Media, Biopreservation Equipment and Biopreservation Accessories. Based on Biospecimen, the market is segmented into Human Tissue Samples, Organs, Stem Cells and Other Biospecimens. Based on Application, the market is segmented into Research Applications, Therapeutic Applications, Other Applications. Based on End User, the market is segmented into Biobanks, Gene Banks, Hospitals and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biopreservation Market

The Global Biopreservation market is significantly driven by the increasing prevalence of chronic diseases worldwide. In developed nations like the United States, over 30% of adults are reported to be affected by these conditions annually, while in developing countries such as India, the figure exceeds 23%. The growing number of chronic disease cases necessitates enhanced diagnostic methods and alternative therapies, which consequently heightens the demand for biopreservation solutions. As healthcare systems strive to manage these diseases effectively, the need for innovative biopreservation techniques to safeguard biological materials becomes essential, further propelling the growth of this market.

Restraints in the Global Biopreservation Market

The Global Biopreservation market faces several restraints primarily revolving around the management of vital environmental factors such as temperature, pressure, and pH, essential for maintaining biomass stability during storage. Achieving effective biopreservation necessitates the use of advanced equipment, specialized consumables, media solutions, and trained personnel, all of which can contribute to elevated costs. Moreover, certain consumables exhibit significant instability and are not readily accessible in the market, further complicating the situation. The substantial initial investment required for setting up biopreservation infrastructure poses a barrier to broader applications across various sectors, limiting the market's overall expansion and accessibility.

Market Trends of the Global Biopreservation Market

The Global Biopreservation market is poised for significant growth, driven by the escalating demand for cell therapy and genetic engineering, anticipated to surge at over 30% CAGR during the forecast period. This trend is catalyzing increased investments from biomedical firms in research and development, as innovative cell and gene therapies revolutionize the diagnosis and treatment of severe and chronic health conditions. Additionally, rising government funding for research centers dedicated to gene therapy and regenerative medicine underscores a robust commitment to advancing these technologies. This confluence of factors positions the biopreservation sector as a crucial player in the future of healthcare.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis

Global Biopreservation Market Size by Product & CAGR (2025-2032)

• Market Overview
• Biopreservation Media
  • Cryopreservation Media
  • Hypothermic Preservation Media
• Biopreservation Equipment
  • Temperature Control Systems
  • Freezers
  • Cryogenic Storage Systems
  • Thawing Equipment
  • Refrigerators
  • Alarm Monitoring Systems
  • Incubators
  • Centrifuges
  • Other Biopreservation Equipment
• Biopreservation Accessories

Global Biopreservation Market Size by Biospecimen & CAGR (2025-2032)

• Market Overview
• Human Tissue Samples
• Organs
• Stem Cells
• Other Biospecimens

Global Biopreservation Market Size by Application & CAGR (2025-2032)

• Market Overview
• Research Applications
• Therapeutic Applications
• Other Applications

Global Biopreservation Market Size by End User & CAGR (2025-2032)

• Market Overview
• Biobanks
• Gene Banks
• Hospitals
• Other End Users

Global Biopreservation Market Size & CAGR (2025-2032)

• North America (Product, Biospecimen, Application, End User)
  • US
  • Canada
• Europe (Product, Biospecimen, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Biospecimen, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Biospecimen, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Biospecimen, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioLife Solutions, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STEMCELL Technologies (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Helmer Scientific Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PrincetonCryo (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OPS Diagnostics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ThermoGenesis Holdings, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avantor, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exact Sciences Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Worthington Industries, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chart Industries, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Azenta US, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LabVantage Solutions, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Taylor-Wharton Cryogenics LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PHC Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Panasonic Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lifeline Scientific, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations